SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001618835-19-000122
Filing Date
2019-06-12
Accepted
2019-06-12 16:36:51
Documents
3
Period of Report
2019-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_156037179598674.html 3  
1 FORM 3 wf-form3_156037179598674.xml 3 1773
2 DOMINIQUE POA poadominique.htm EX-24 604
3 DOMINIQUE POA poadominique001.jpg GRAPHIC 200335
  Complete submission text file 0001618835-19-000122.txt   279917
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Issuer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALEXION PHARMACEUTICALS, INC. 352 KNOTTER DRIVE CHESHIRE CT 06410
Business Address
Monnet Dominique (Reporting) CIK: 0001632798 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36754 | Film No.: 19893966